NXG Nexgenrx Inc

NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to
announce its 2013 annual results.


Revenue from transaction fees for the year ended December 31, 2013 was
$4,910,517 representing an increase of 12%, cost of sales decreased by 11% and
gross profit increased by 18% over the prior year.


The net income for the year was $608,549, $0.01 per common share, compared with
523,692 in the prior year.


"2013 was a year of significant financial accomplishments focused on revenue
growth producing eight consecutive quarters of positive operating cash flow of
$969,865 and generating $608,549 of net income for the year. During 2013 we
hired our VP of Sales plus two additional personnel and launched our new sales
strategy focused on our next phase of growth. The strength of combining our
claims adjudication solution, NexSys(R), with NexAdmin(R), our fully web- based
administration platform, provides plan sponsors with superior
self-administration functionality and complete control of their own data,
independent of any insurance carrier," stated Ron Loucks, President and CEO.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com.


Caution Regarding Forward-Looking Statements - This news release contains
certain forward-looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of the release."


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416.695.3393 x803
www.nexgenrx.com

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Nov 2024 to Dec 2024

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Dec 2023 to Dec 2024